The MOVe-In advance study is ongoing so we need to look ahead to the analyze to get complete or interim benefits become accessible in advance of We all know if or how nicely molnupiravir prevents COVID-19. For that reason molnupiravir is NOT licensed to circumvent COVID-19.  = 0.03 for group difference; https://bonon887cpz1.robhasawiki.com/user